Abstract-Magnetic Resonance Navigation (MRN) relies on Magnetic Nanoparticles (MNPs) embedded in microcarriers or microrobots to allow the induction of a directional propelling force by 3-D magnetic gradients. These magnetic gradients are superposed on a sufficiently high homogeneous magnetic field (e.g. the Bo field of a MR scanner) to achieve maximum propelling force through magnetization saturation of the MNPs. As previously demonstrated by our group, such technique was successful at maintaining microcarriers along a planned trajectory in the blood vessels based on tracking information gathered using Magnetic Resonance Imaging (MRI) sequences from artifacts caused by the same MNPs. Besides propulsion and tracking, the same MNPs can be synthesized with characteristics that can allow for the diffusion of therapeutic cargo carried by these MR-navigable carriers through the Blood Brain Barrier (BBB) using localized hyperthermia without compromising the MRN capabilities. In the present study, localized hyperthermia induced by an alternating magnetic field (AC field) is investigated for the purpose of transient controlled disruption of the BBB and hence local delivery of therapeutic agents into the brain. Here, an external heating apparatus was used to impose a regional heat shock on the skull of a living mouse model. The effect of heat on the permeability of the BBB was assessed using histological observation and tissue staining by Evans blue dye. Results show direct correlation between hyperthermia and BBB leakage as well as its recovery from thermal damage. Therefore, in addition to on-command propulsion and remote tracking, the proposed navigable agents could be suitable for controlled opening of the BBB by hyperthermia and selective brain drug delivery.
I. INTRODUCTION
RAIN tumours are extremely lethal and incredibly invasive and therefore, intervening with complex surgery is a top priority in most medical cases. Despite many efforts, drug delivery to the brain remains a challenge mainly because the Blood Brain-Barrier (BBB), which consists of endothelial cells that are tightly interconnected and cover all the interior of the cerebral vessel walls, is reputed to be insurmountable for most therapeutic molecules. In fact, nearly 98% of new drugs used in the Central Nervous System (CNS) to combat brain cancer and other chronic diseases cannot enter the brain following systemic administration [1] . On the other hand, systemic administration of toxic agents causes the active principles to distribute throughout all the organs. Therefore, while pathological regions are treated, they also promote side effects in healthy organs.
The extremely selective permeability of BBB and high cytotoxicity of anticancer drugs reinforce the importance of non-invasive targeted drug delivery for brain tumours and other chronic brain related disorders. Previously, our team has shown successful local delivery and tracking of therapeutic agents encapsulated in miniaturized magnetic carriers in the liver of a living animal by the gradient field of a modified Magnetic Resonance Imaging (MRI) scanner [2, 3] . The proposed carriers consist of therapeutic molecules and aggregates of Magnetic Nanoparticles (MNPs) with relatively high magnetization saturation embedded inside a biocompatible and biodegradable polymer, which serves as a transport mediator in the vasculature. This encapsulation also functions as a protective shield and prevents cells from further exposure to toxic drugs during the carriers' commute to a target area.
Besides MR-propulsion and MR-tracking, the same MNPs can be synthesized to offer characteristics that will allow them to become magnetically excited by an alternating field (AC field) and to release their energy in the form of heat to their surrounding area. Inside brain microvasculature, such heat may thermally disrupt an intact BBB thereby creating a transient opening for the therapeutic agents to cross into the brain tissue. In fact, it has long been recognized that hyperthermia, otherwise known as elevation of body temperature, can lead to intense cellular stress and cause temporal disruption of the BBB [4] [5] [6] [7] as well as death of cancer cells by enhancing cell sensitivity and vulnerability towards more established forms of cancer therapy, such as radiation and chemotherapy [8] is based on excitation of MNPs inside an AC field [9] . This technique makes use of the radiofrequency of electromagnetic waves to heat the MNPs and therefore it is just as effective in deep biological structures as it is at the surface. To our knowledge, hyperthermic disruption of the BBB via induction of MNPs by an AC field for drug delivery to the brain has not yet been reported. Here, the feasibility of this technique, as well as its integration with our pioneered MRI-based propulsion and tracking technique for intervention of microcarriers and microrobots in the vasculature are discussed. Furthermore, results in this study suggest that there may be a direct relationship between the elevated brain tissue temperature and the extent of the penetration of the desired drug molecules across the BBB. This implies that by controlling the amount of heat and exposure time, we can adjust the BBB opening for various molecular dimensions. Finally in this study, the recovery of the BBB from thermal damage is examined and investigated.
Although this is a preliminary study, it is in light of such technique that non-invasive local drug delivery to the region of the brain may become possible.
II. BACKGROUND INFORMATION

A. Blood-Brain Barrier (BBB)
All capillaries in the mammalian body including humans are composed of endothelial cells. In the circumventricular organs, most of the capillaries are fenestrated to allow for rapid exchange of molecules such as the therapeutic agents between blood vessels and surrounding tissue. In the rest of the brain however, very complex inter-endothelial tight junctions interconnect the endothelial cells. The tight junctions seal the cell interspace and form a diffusion barrier that markedly controls the flow of molecules across the epithelium. In addition to the tight junctions, pericytes with smooth muscle-like properties constitute the BBB [10] . Only small electrically neutral lipid-soluble compounds with low molecular mass of less than 400-500 Daltons (Da), or those small electrically neutral lipid-soluble compounds with low air-water partition coefficients and an average crosssectional area of 50 Å 2 , are able to diffuse passively through the BBB [11] [12] [13] . As mentioned before, this restrains admission of a considerable portion of pharmaceutical agents into the brain. For instance, currently many large drug molecules such as peptides, recombinant proteins, monoclonal antibodies, antisense and non-viral gene medicines are ineffective for the brain [14] .
One of the main functions of the BBB is to keep the neurotransmitters and agents that act in the CNS separate from the peripheral tissues and blood, so that similar agents can be used in the two systems without 'cross-talk' [15] . Also, because of the BBB's large surface area (180 cm 2 per gram brain [13] ) and the short diffusion distance between neurons and capillaries (8-20 µm [16] ), the extent to which a molecule enters the brain is determined only by the permeability characteristics of the BBB and that has a predominant role in regulating the brain microenvironment. That is why circumventing the BBB is a priority for any drug delivery mechanism to the region of the brain. Successful crossing of this barrier will have a profound effect on the treatment of many brain related disorders and therefore hyperthermia is being investigated for that purpose.
B. Hyperthermia
In modern oncology, hyperthermia generally refers to heating of organs or tissues in various ways to temperatures between 40°C and 45°C, at which point it causes moderate and reversible cellular inactivation [8] . In this regard, induction of MNPs by an AC field has been investigated for elevation of tissue temperature on a variety of fronts. Chief among those is the fact that the MNPs can act as very small heat sources once placed in an AC field, regardless of their depth inside the biological entity. On the contrary, other techniques such as RF, microwave and High Intensity Focused Ultrasound (HIFU), are not able to accurately target desired deep-seated tissues.
During local hyperthermia to temperatures near 42°C in the region of the brain (T = 5°C), morphological changes of individual endothelial cells in the monolayer lining of the micro-vessels begin to cause the tight junctions between adjacent endothelial cells to loosen, therefore allowing transport of large molecules through intercellular pathway [17] . Fortunately, the BBB seems to have the capability to restore functionality after brief hyperthermic disruption [18] . The rate of this restoration however, depends on the amount of heat and the exposure time.
C. Magnetic Nanoparticles (MNPs)
Among various methods of hyperthermia, whole body [5] , microwave [6] and radiofrequency hyperthermia [7] are most commonly used to disrupt the BBB. In these techniques an entire region of the brain including neurons, astrocytes, vessel wall cells, and other glial cells are equally heated. In fact, this may be the reason for many undesirable acute side effects with hyperthermic disruption of the BBB by these techniques. Conversely, in the proposed hyperthermic disruption of the BBB by induction of MNPs inside an AC field, heat is exclusively dissipated to the ambient vessel wall cells by thermal conduction. Consequently, only the monolayer lining of the vessel walls and the endothelial cells are directly affected by the thermal stress.
The Specific Absorption Rate (SAR) or heat generated by the MNPs is mainly caused by three major mechanisms; hysteresis loss, Néel, and Brownian relaxations. Particles' physical properties as well as magnitude and frequency of the applied AC field determine the relative strength of each of these mechanisms. SAR is proportional to the time rate of change of temperature of a magnetic material and is given by the following formula [19] : (1) In (1), c is the specific heat capacity of the sample (Jl -1 K -1 ), m is the mass of the magnetic particles (kg), is the total volume (m 3 ) and expressed in ºKs -1 , is the temperature increment which is experimentally derived from the linear regression of the initial data points obtained from the time varying temperature curve. In the steady state, the difference in temperature is given by (2) where is the concentration of the MNPs (mass of the particles per tissue volume) and represents the heat conductivity of a tissue volume with a radius R [20] . (2) From (2) it is evident that higher concentration of MNPs per unit volume of the tissue leads to higher. In reality, for most therapeutic applications, the relatively poor energy transfer efficiency of the MNPs, i.e. poor SAR, introduces a great obstacle that hinders full functionality or demands large administration of the MNPs at the biological target location leading to an increase in possible side effects. Therefore, scientists have long been searching for MNPs with the highest possible SAR.
In contrast to other forms of magnetization, superparamagnetism can prevent formation of nanoparticle clusters in the biological entity [9] . That is why ultra-small magnetite or superparamagnetic iron oxide (magnetite: Fe 3 O 4 ) nanoparticles have been given special attention for hyperthermia. These particles are commercially available and their physical properties are vastly studied. In addition, magnetite nanoparticles have shown great biocompatibility, biodegradability and low toxicity [21] . The SAR value of these particles varies with respect to particle diameter and magnetic properties of the AC field. Our previous studies with superparamagnetic magnetite nanoparticles have shown promising results with regards to hyperthermia [22] . Table 1 summarizes some of the key parameters required to elevate the temperature of the brain tissue from 37°C to 42°C using commercially available particles. These parameters are induced from numerous in-vitro experiments and simulations presented in [23] . In the same table, MNPs with much higher SAR but not yet commercially available are also reported. The main difficulty of localized hyperthermic disruption of the BBB by induction of the MNPs is transportation of the MNPs and therapeutic agents through the vasculature to a desired area of the brain. Several criteria have been foreseen for such transportation. First, the carrier must have the ability to geometrically fit into the target microvasculature. Second, the carrier must allow for maximum MNPs concentration at the target area to reach sufficient thermal levels. It is also very important to consider factors such as immunological reactions, excessive toxicity, premature degradation and fast excretion of the carrier by blood enzymes, or unexpected capture by non-targeted tissues that may affect the carrier behavior. Compositions such as polyglycolic acid (PGA), poly(lactic-co-glycolic acid) (PLGA), and various environment-sensitive hydrogels are some of the well-known biomaterials for this purpose [25] .
D. MRI-Based Drug Delivery System
Magnetic nanoparticles experience a thrust force when exposed to a gradient field. As seen in (4), this magnetic force, (N) is directly proportional to the volume of the MNPs, (m 3 ) and their magnetization properties, (Am -1 ) as well as the gradient of the magnetic field, (T) [26] . (4) Magnetic Drug Targeting (MDT) technique uses this to concentrate therapeutic drugs adsorbed, entrapped or covalently linked to aggregates of MNPs at a superficial target location following a local intravenous injection [27] .
The main difficulty for this technique however, is that it lacks the ability to target deep tissues [9] . Therefore, instead of a conventional approach most often based on an external magnet, an improved alternative method based on the three dimensional gradient magnetic field of the MRI was proposed by our team [28] . In this technique, due to the large main magnetic field of the MRI, aggregates of the MNPs become magnetically saturated once inside the relatively high homogeneous field of a clinical MRI scanner and therefore, relatively small shifts in the gradient field can steer them towards a target anywhere in the tissue. Furthermore, the aggregates of the MNPs create a magnetic distortion on the images acquired by MRI sequences. Therefore, the same MRI platform is able to track the aggregates in real-time and confirm their presence at the target. In order to maneuver in the microvasculature, and to avoid fast degradation of the MNPs in the blood circulation system, as well as preventing them from dissociation, which greatly limits the thrust force and distortion for tracking purposes, the MNPs along with the therapeutic agents must be encapsulated in biocompatible micrometer size carriers. Previously, our team was able to synthesize such complex microcarriers and to use them to target a specific region of the liver of a living rabbit [3] prior to the successful release of the therapeutic agent. The vascular structure of the liver however is very different from that of the brain. Therefore, the proposed micro-entities may require appropriate modifications before attempting MRN towards the brain.
III. METHOD
Various studies evaluated the required amount of thermal exposure and duration for temporal disruption of the BBB based on imposition of thermal stress on the tight junctions [29, 30] . According to the findings of these studies, the ideal temperature for transient disruption of the BBB falls in the range of 42°C-44°C for a period of 30 minutes.
A. BBB Staining
Staining of the BBB is a traditional method for evaluating BBB leakage. Evans blue, an exogenous dye tracer is used here to assess the integrity of the BBB following a hyperthermic disruption. The dye molecules are able to easily diffuse through the fenestrated endothelial cells of all capillaries except those of the brain due to a functional BBB. However, once the BBB is compromised, Evans blue enters the brain and it fluoresces with excitation peaks at 470 and 540 nm and an emission peak at 680 nm [31] . Histological staining techniques can therefore reflect the extent of BBB leakage by studying the intensity of Evans blue dye in the brain. 
B. Experimental Procedure
In the primary steps of this study, distribution of heat from an external heating device on the brain of living mice as well as feasibility studies in regards to hyperthermic disruption of the BBB were assessed. For this purpose, a two-phase invivo experiment was executed:
1) Phase i
Five mice were separately anesthetised by intravenous injection of 40mg/kg body weight of pentobarbital. Quickly after, each animal was positioned on a stereotaxic frame and the head of the animal was secured in place. Then, by removing the skin, the surface of the skull of the animal was exposed. At this point, four small holes (~1mm in diameter) were drilled into the skull at precise locations shown in Fig.  1a . Next, fibre optic thermocouples were placed inside the holes. An external heating device was used to focally elevate the temperature of a small region of the brain near Bregma (see Fig. 1c.) at a 40° angle for duration of 30 minutes. While the thermocouples recorded changes in temperature at specific distances (1, 2, 3, 5mm respectively) away from the heating point (see Fig. 1b.) , a rectal thermometer monitored the internal body temperature of the animal. Since the body temperature drops rapidly during anaesthetic state, each animal was placed on a thermal pad. In addition, a heating lamp was placed 5 cm above the skull to keep the brain temperature at 37°C during the experiment. As a consequence, the body temperature was always kept at 36.5°C to 37°C.
The purpose of this experiment was to examine the thermal distribution in the brain tissue. This resulted in a thermal map of the tissue represented in Section IV. It is important to mention that, the environment in the experimental suite was kept thermally neutral during all experiments.
2) Phase ii
The purpose of this part of the experiment was to examine the feasibility of hyperthermic disruption of the BBB as well as its recovery period from thermal damage using Evans blue staining technique. Here, nine mice, each 6-8 weeks of age, were randomly divided into three identical groups. In contrast to the previous part, no holes were drilled into the exposed surface of the skull of these animals. In order to correlate temperature patterns with stains left from the Evans blue dye, the heating parameters for all groups were kept the same as was described in the first part of this experiment.
a)
Group I All mice in this group were intravenously injected with 40mg/kg of body weight of pentobarbital and 4ml/kg body weight 2% Evans blue dye. As in Part i, quickly after anaesthesia each animal was positioned on a stereotaxic frame where a thermal pad and the lamp kept the body temperature steady at near 37°C. Just as before, the heating device was also placed at a 40° angle near and above Bregma and the exposure time was set to 30 minutes. All animals in this group were sacrificed one hour after injection of the dye. The animals' brains were extracted and immersed in isopentane and kept on dry ice for further analysis.
b) Group II
To examine BBB's ability to recover following hyperthermic disruption, all mice belonging to this group were prepared the same way as done in Group I except that the dye was injected 2 hours after 30 minutes of thermal treatment had ended. Exactly one hour after injection of the dye, the animals were sacrificed and their brains were removed, immersed in isopentane and kept on dry ice for further study.
c)
Group III All mice in this group served as controls and were injected with the Evans blue and before they were sacrificed. There was no staining of the dye found on the brain tissue of the mice from this group.
C. Data Analysis Extracted brains were embedded in Optimal Cutting
Compound where 50-micron coronal slices were made at 20°C in a cryostat. Results are shown in the next Section.
IV. RESULTS
Results from the first part of the experiment are shown in Fig. 2 . In this figure, recorded temperatures from 1mm and 2mm distances away from the heating device quickly raised once heating started and rapidly plateaued at approximately 44.3°C and 39.4°C respectively. Also, at the distances of 3mm and 5mm away from the heating device, temperatures reached 37.8°C and 37.6°C respectively.
VI. CONCLUSION
The main goal of modern pharmacology is the transport of drug molecules to specific targets while maintaining therapeutic efficacy. However, nearly 98% of drugs cannot enter the brain following systemic administration. Our group has previously pioneered a MRI-based drug delivery platform referred to as MRN that employs microcarriers or future microrobots capable of interventions in the vasculature. Here, our team is looking to equip these microentities with hyperthermic capabilities to disrupt the BBB and therefore be as effective in delivering therapeutic agents in the brain. This ability comes from the fact that these micro-entities rely on embedded MNPs that are excited once placed inside an AC field. This excitation leads to moderate elevation of temperature and thus transient disruption of the BBB. In light of this technique, local drug delivery for various disorders such as brain tumours, psychiatric, neurological and neurodegenerative disorders may also become feasible.
